The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD
This pilot study will examine the safety, tolerability, acceptability, and efficacy of combination psilocybin + psychotherapy to decrease PTSD symptoms. Participants will be randomized into two different treatment groups, allowing the investigators to directly compare PE augmented with psilocybin and psilocybin-assisted psychotherapy.
- Status
- planned
- Phase
- Phase 2
- Institution
- Emory University
- Principal investigator
- Anna Wise, PhD
- Start date
- 2026-06-01
- End date
- 2027-03-01
- Registry ID
- NCT07332143
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.